Compare TG Therapeutics Inc (TGTX) vs Waste Management, Inc. (WM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs Waste Management, Inc. — how do they compare? TG Therapeutics Inc trades at $54.06 (market cap $8.26B), while Waste Management, Inc. trades at $233.4 (market cap $96.00B). The key difference: Waste Management, Inc. is far larger — about 11.6× TG Therapeutics Inc's market cap, and Waste Management, Inc. pays a 1.48% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | WM | |
|---|---|---|
Market Cap | $8.26B | $96.00B |
Sector | Health | Industrials |
52-Week High | $59.06 | $246.51 |
52-Week Low | $26.39 | $196.77 |
Enterprise Value | $8.50B | $118.73B |
Dividend Yield | — | 1.48% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →
